A detailed history of National Pension Service transactions in Biogen Inc. stock. As of the latest transaction made, National Pension Service holds 359,569 shares of BIIB stock, worth $62.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
359,569
Previous 326,655 10.08%
Holding current value
$62.5 Million
Previous $75.7 Million 7.96%
% of portfolio
0.07%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$189.07 - $236.8 $6.22 Million - $7.79 Million
32,914 Added 10.08%
359,569 $69.7 Million
Q2 2024

Aug 12, 2024

BUY
$190.52 - $236.72 $2.39 Million - $2.97 Million
12,539 Added 3.99%
326,655 $75.7 Million
Q1 2024

May 13, 2024

BUY
$212.02 - $267.71 $2.5 Million - $3.16 Million
11,799 Added 3.9%
314,116 $67.7 Million
Q4 2023

Feb 06, 2024

BUY
$222.59 - $267.94 $1.42 Million - $1.71 Million
6,375 Added 2.15%
302,317 $78.2 Million
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $3.73 Million - $4.21 Million
14,730 Added 5.24%
295,942 $76.1 Million
Q2 2023

Aug 15, 2023

BUY
$275.25 - $318.06 $3.82 Million - $4.41 Million
13,881 Added 5.19%
281,212 $80.1 Million
Q1 2023

May 11, 2023

BUY
$256.56 - $292.34 $17.4 Million - $19.8 Million
67,806 Added 33.98%
267,331 $74.3 Million
Q4 2022

Feb 23, 2023

SELL
$252.44 - $306.72 $1.55 Million - $1.88 Million
-6,127 Reduced 2.98%
199,525 $55.3 Million
Q4 2022

Feb 17, 2023

SELL
$252.44 - $306.72 $1.55 Million - $1.88 Million
-6,127 Reduced 2.98%
199,525 $55.3 Million
Q3 2022

Feb 23, 2023

BUY
$194.69 - $268.46 $1.19 Million - $1.64 Million
6,127 Added 3.07%
205,652 $54.9 Million
Q3 2022

Nov 17, 2022

SELL
$194.69 - $268.46 $1.63 Million - $2.24 Million
-8,362 Reduced 3.91%
205,652 $54.4 Million
Q2 2022

Aug 17, 2022

BUY
$187.54 - $223.02 $525,674 - $625,125
2,803 Added 1.33%
214,014 $43.6 Million
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $6.83 Million - $8.6 Million
-35,230 Reduced 14.3%
211,211 $44.5 Million
Q4 2021

Feb 15, 2022

SELL
$223.92 - $287.77 $235,339 - $302,446
-1,051 Reduced 0.42%
246,441 $59.1 Million
Q3 2021

Nov 18, 2021

SELL
$282.99 - $369.05 $1.73 Million - $2.26 Million
-6,130 Reduced 2.42%
247,492 $70 Million
Q2 2021

Aug 17, 2021

BUY
$259.0 - $414.71 $1.19 Million - $1.91 Million
4,600 Added 1.85%
253,622 $87.8 Million
Q1 2021

May 14, 2021

SELL
$242.95 - $284.63 $1.39 Million - $1.63 Million
-5,726 Reduced 2.25%
249,022 $69.7 Million
Q4 2020

Feb 19, 2021

BUY
$236.26 - $355.63 $1.17 Million - $1.76 Million
4,961 Added 1.99%
254,748 $62.4 Million
Q2 2020

Aug 11, 2020

SELL
$258.66 - $342.55 $1.95 Million - $2.58 Million
-7,546 Reduced 2.93%
249,787 $66.8 Million
Q1 2020

May 27, 2020

BUY
$268.85 - $341.04 $814,077 - $1.03 Million
3,028 Added 1.19%
257,333 $81.4 Million
Q4 2019

Feb 21, 2020

SELL
$220.06 - $304.07 $253,949 - $350,896
-1,154 Reduced 0.45%
254,305 $75.5 Million
Q3 2019

Nov 15, 2019

BUY
$217.44 - $243.88 $2.45 Million - $2.75 Million
11,261 Added 4.61%
255,459 $59.5 Million
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $6.83 Million - $7.53 Million
31,150 Added 14.62%
244,198 $57.1 Million
Q1 2019

May 15, 2019

BUY
$216.71 - $338.96 $1.72 Million - $2.68 Million
7,921 Added 3.86%
213,048 $50.4 Million
Q4 2018

Feb 15, 2019

BUY
$278.5 - $352.75 $3.18 Million - $4.03 Million
11,434 Added 5.9%
205,127 $66.6 Million
Q3 2018

Nov 15, 2018

SELL
$293.51 - $383.83 $284,998 - $372,698
-971 Reduced 0.5%
193,693 $68.4 Million
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $3.03 Million - $3.61 Million
11,770 Added 6.44%
194,664 $56.2 Million
Q1 2018

Apr 13, 2018

BUY
$260.13 - $367.91 $1.19 Million - $1.68 Million
4,575 Added 2.57%
182,894 $50.1 Million
Q4 2017

Jan 17, 2018

BUY
$307.64 - $344.58 $552,521 - $618,865
1,796 Added 1.02%
178,319 $56.8 Million
Q3 2017

Oct 16, 2017

BUY
$281.15 - $329.69 $49.6 Million - $58.2 Million
176,523
176,523 $54.7 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track National Pension Service Portfolio

Follow National Pension Service and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Pension Service, based on Form 13F filings with the SEC.

News

Stay updated on National Pension Service with notifications on news.